Table 1 Cohort characteristics
| Â | Male | Female |
|---|---|---|
Gender, n (%) | 22 (63) | 13 (37) |
Age at OMT-start, years, mean (range) | 37.3 (29.4 – 50.5) | 37.5 (27.3 – 50.3) |
OMT medication, methadone, n | 19 | 11 |
OMT medication, buprenorphine, n | 3 | 2 |
Methadone dosage mg, median (range) | 132.5 (100 – 220) | 145 (100 – 170)* |
Buprenorphine dosage mg, median (range) | 22(16 – 32) | 22 (20 – 24) |
HCV antibody positive, n (%) | 21 (95.5) | 13 (100) |
Receiving anti HCV treatment during OMT, n | 1 | 0 |
HIV antibody positive, n | 0 | 0 |
Died during OMT, n | 0 | 0 |